You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Growth was driven by two<br />
factors: for one thing, sales<br />
momentum picked up again as<br />
volumes increased; for another,<br />
expansion was driven by<br />
acquisitions along with<br />
favorable exchange rates.<br />
With its strong position in electronic<br />
materials and fine<br />
chemicals, <strong>Clariant</strong> is now well<br />
placed in two future-oriented<br />
markets with considerable<br />
growth potential.<br />
A message from the Chairman<br />
Seizing change as an opportunity<br />
<strong>Clariant</strong> has had an eventful year, scoring a number of<br />
successes but also suffering some disappointments. On<br />
the one hand, with the successful takeover of the British<br />
company BTP we reached a strategic milestone in the<br />
promising area of fine chemicals; this step has made us<br />
into a leading partner for the pharmaceutical and agrochemical<br />
industries. On the other hand, though, the price<br />
of our share plummeted as the stock market turned its<br />
back on traditional industrial stocks. Fortunately, our<br />
employees have not allowed themselves to be distracted<br />
by the vagaries of the market and have persistently<br />
focused on strengthening the company's performance<br />
and growth potential. I would like to take this opportunity<br />
to thank all of you for this achievement.<br />
Divisional sales in <strong>2000</strong> climbed by +16% from CHF<br />
9,158 million to CHF 10,583 million. This growth was<br />
driven by two factors: for one thing, sales momentum<br />
picked up again as sales volumes increased; for another,<br />
expansion was driven by acquisitions along with favorable<br />
exchange rates. Operating profit before goodwill<br />
amortization rose CHF 53 million to CHF 1,135 million<br />
from the year-back figure of CHF 1,082 million. Adjusted<br />
for one-off revenues in the previous year, the improvement<br />
comes to CHF 118 million or +12%. The steep<br />
increase in the price of raw materials (the bill swelled by<br />
some CHF 200 million) could only be partially offset by<br />
passing on higher prices to customers, and then only<br />
with a time lag. <strong>Clariant</strong> met this reduction in earnings<br />
head on by initiating measures to cut costs and increase<br />
efficiency, and the impact of these moves will be felt in<br />
future too. Net income after minorities fell by –14% from<br />
CHF 587 million to CHF 505 million, owing in particular to<br />
additional acquisition-related goodwill amortization and<br />
higher financing costs connected with the takeover of<br />
BTP. Earnings per share accordingly declined from CHF<br />
41.13 to CHF 34.14. However, earnings per share before<br />
goodwill amortization (“cash earnings”) increased from<br />
CHF 42.39 to CHF 42.61. Given the positive outlook for<br />
the future, the Board of Directors will propose to the<br />
company's shareholders to raise the dividend by +10%<br />
from CHF 10 to CHF 11 per share.<br />
The stock market turned its back on the specialty<br />
chemical sector, pushing down share prices for the<br />
industry as a whole and for <strong>Clariant</strong> in particular. The<br />
reasons investors gave for this trend – which we do not<br />
understand – are according to their opinion the more<br />
attractive investment opportunities to be found in other<br />
industries, the slowdown in the chemical sector and the<br />
steep rise in commodity prices. However, we were never<br />
forced to issue a profit warning because our business is<br />
broad-based and we are able to respond to business<br />
challenges swiftly. Nonetheless, over the year the share<br />
price fell to a 12-month low of CHF 461, though it did<br />
rally to finish at CHF 581.<br />
As regards strategy, we forged ahead with the implementation<br />
of the Strategic Plan that was adopted in<br />
1999. The takeover of BTP in the spring marked a major<br />
step in this direction. The product ranges, the know-how<br />
in chemical technology and the two management teams<br />
are all a perfect fit. We are confident that the pharmaceutical<br />
and agrochemical industries will increasingly<br />
turn to specialist fine chemical manufacturers for the<br />
production of their intermediates and active ingredients.<br />
With its strong position in electronic materials, <strong>Clariant</strong><br />
is now well placed in two future-oriented markets with<br />
considerable growth potential. At the same time as we<br />
expand in our strategic growth areas, we will continue to<br />
dispose of semispecialty and specialty activities this<br />
year in order to streamline our business portfolio. The<br />
areas affected are those with insufficient growth and<br />
earnings potential as well as businesses that are of little<br />
strategic interest to <strong>Clariant</strong> despite their good performance<br />
and that would flourish better in a more suitable<br />
environment.<br />
At the operational level, the strong performance by<br />
the divisions and local Group companies makes confident<br />
about the future: production plants were further<br />
optimized and adapted to meet market needs and, we<br />
are very pleased by the increased share of new and innovative<br />
products. This success, however, should not blind<br />
us to the fact that 2001 will be yet another very challenging<br />
year. The chemical industry is still in flux, and we<br />
are bound to see further changes in the environment. Our<br />
Exactly your chemistry.<br />
3